Surgical valve technologies
Dedicated to improving the lives of patients with structural heart disease, our commitment to transformational heart valve technology began in 1960 with the first commercially available heart valve.
Edwards has continued to meaningfully advance heart valve therapy, and, more than 50 years later, we remain a global leader in this field. Our offerings include tissue replacement heart valves and repair products, as well as, transcatheter heart valves for those patients considered at high or greater risk for conventional valve replacement.
Edwards’ leadership in transcatheter heart valve replacement includes a commitment to meaningful innovation, rigorous scientific study, extensive clinician training and education, and significant investment in new applications of the technology.
Edwards also offers market-leading technologies that facilitate on-pump cardiac surgery procedures through smaller incisions. Edwards’ minimally invasive valve surgery solutions are comprised of soft tissue retractors, venous and arterial cannulae, aortic occlusion, venting, and coronary sinus catheters.
